These results, together with a previous report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two help the strategy of targeting ACKR3 as a unique technique to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated Diseases. As well as the described https://joanb792cyu2.blogpixi.com/profile